These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3498125)

  • 21. Humoral and cellular immunity in progressive systemic sclerosis.
    Sierakowski S; Bernacka K
    Med Interne; 1987; 25(4):233-8. PubMed ID: 3501150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebrospinal fluid (CSF) parameters and clinical course of multiple sclerosis.
    Livrea P; Simone IL; Trojano M; Pisicchio L; Logroscino G; Rosato A
    Riv Neurol; 1987; 57(3):189-96. PubMed ID: 3672011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Thymus-dependent and thymus-independent blood lymphocytes in multiple sclerosis].
    Khondkarian OA; Gannushkina IV; Zavalishin IA; Zhirnova IG; Nevskaia OM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(3):32-6. PubMed ID: 6602442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunology of multiple sclerosis. Recent data and therapeutic perspectives].
    Tourbah A; Fontaine B; Lyon-Caen O
    Rev Neurol (Paris); 1993; 149(6-7):373-84. PubMed ID: 8303156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoglobulin abnormalities in multiple sclerosis.
    Link H
    Ann Clin Res; 1973 Oct; 5(5):330-6. PubMed ID: 4209372
    [No Abstract]   [Full Text] [Related]  

  • 26. [Experience in using T-activin in multiple sclerosis patients].
    Gusev EI; Arion VIa; Aristova RA; Ivanokov AN; Tunkel' OI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(2):168-74. PubMed ID: 6608843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro stimulated peripheral blood lymphocytes from multiple sclerosis patients produce idiotypes of oligoclonal CSF IgG.
    Nagelkerken LM; Out TA
    J Immunol; 1983 Nov; 131(5):2328-31. PubMed ID: 6685156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Role of autoimmunity in multiple sclerosis].
    Chabas D; Liblau R
    Pathol Biol (Paris); 2000 Feb; 48(1):25-46. PubMed ID: 10729910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mechanism of formation of active T-rosette forming cells in multiple sclerosis patients].
    Matveeva TV; D'iakonova IN; Shaĭdullina FS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(2):21-5. PubMed ID: 6972132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunological aspects in multiple sclerosis. I. Lymphocyte subpopulations and antilymphocyte antibodies].
    Tilbery CP; Lima JG; Scheimberg MA
    Rev Paul Med; 1987; 105(3):134-40. PubMed ID: 3502426
    [No Abstract]   [Full Text] [Related]  

  • 31. [T- and B-lymphocyte counts and their function in patients with primary liver cancer and alveococcosis].
    Strazhnikova GA; Sukhorukov VP; Voronchikhina LD; Korshunova TP; Gornostaeva GN
    Vopr Onkol; 1984; 30(1):56-9. PubMed ID: 6607570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Humanized anti-CD25 antibody treatment with daclizumab in multiple sclerosis.
    Martin R
    Neurodegener Dis; 2008; 5(1):23-6. PubMed ID: 18075271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular and humoral immune responses against autoreactive T cells in multiple sclerosis patients after T cell vaccination.
    Hermans G; Denzer U; Lohse A; Raus J; Stinissen P
    J Autoimmun; 1999 Sep; 13(2):233-46. PubMed ID: 10479392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunotoxicity profile of natalizumab.
    Wehner NG; Gasper C; Shopp G; Nelson J; Draper K; Parker S; Clarke J
    J Immunotoxicol; 2009 Jun; 6(2):115-29. PubMed ID: 19589098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrospinal fluid T cell clones from patients with multiple sclerosis: recognition of idiotopes on monoclonal IgG secreted by autologous cerebrospinal fluid B cells.
    Holmøy T; Fredriksen AB; Thompson KM; Hestvik AL; Bogen B; Vartdal F
    Eur J Immunol; 2005 Jun; 35(6):1786-94. PubMed ID: 15864781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal analysis of immune cell phenotypes in early stage multiple sclerosis: distinctive patterns characterize MRI-active patients.
    Rinaldi L; Gallo P; Calabrese M; Ranzato F; Luise D; Colavito D; Motta M; Guglielmo A; Del Giudice E; Romualdi C; Ragazzi E; D'Arrigo A; Dalle Carbonare M; Leontino B; Leon A
    Brain; 2006 Aug; 129(Pt 8):1993-2007. PubMed ID: 16870883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Magnetic Resonance Imaging study of the role of the blood-brain barrier in the pathogenesis of experimental allergic encephalomyelitis: application to multiple sclerosis].
    Chambron J; Namer IJ; Steibel J; Gounot D; Armspach JP
    Bull Acad Natl Med; 1994 Dec; 178(9):1647-63; discussion 1663-5. PubMed ID: 7788436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of three FcR-positive T cell subsets (T gamma, T mu and T gamma mu) in the cerebrospinal fluid of multiple sclerosis patients.
    Merrill JE; Biberfeld G; Landin S; Sidén A; Norrby E
    Clin Exp Immunol; 1980 Nov; 42(2):345-54. PubMed ID: 6970641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of T- and B-cell immunity of regional lymph nodes in patients with skin melanoma and prognosis of the disease].
    Serov AA; Kadagidze ZG
    Vopr Onkol; 1983; 29(12):18-20. PubMed ID: 6607569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isoprinosine in multiple sclerosis treatment: a preliminary study.
    Mazzarello P; Rocchelli B; Poloni M; Delodovici M; Pinelli P
    Schweiz Arch Neurol Neurochir Psychiatr; 1982; 131(2):175-9. PubMed ID: 6187064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.